Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Operating Expenses (2016 - 2025)

Nephros has reported Operating Expenses over the past 16 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Operating Expenses at $2.7 million for Q4 2025, up 27.11% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (up 20.21% YoY), and the annual figure for FY2025 was $10.5 million, up 20.21%.
  • Operating Expenses for Q4 2025 was $2.7 million at Nephros, up from $2.6 million in the prior quarter.
  • Over the last five years, Operating Expenses for NEPH hit a ceiling of $2.7 million in Q4 2025 and a floor of $1.9 million in Q3 2024.
  • Median Operating Expenses over the past 5 years was $2.4 million (2021), compared with a mean of $2.4 million.
  • Biggest five-year swings in Operating Expenses: dropped 19.18% in 2024 and later soared 33.87% in 2025.
  • Nephros' Operating Expenses stood at $2.2 million in 2021, then grew by 0.46% to $2.2 million in 2022, then rose by 21.25% to $2.7 million in 2023, then decreased by 19.18% to $2.2 million in 2024, then grew by 27.11% to $2.7 million in 2025.
  • The last three reported values for Operating Expenses were $2.7 million (Q4 2025), $2.6 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.